Feasibility of Online MR-guided Radiotherapy on a 1.5T MR-Linac
Recruiting
N/A
Interventional Study
Rectal Cancer
Head and Neck Cancer
Liver Cancer
Breast Cancer
Prostate Cancer
Oligometastasis
Esophageal Cancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 472 (estimated)
- Sponsor
- University Hospital Tuebingen · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study investigates the feasibility of imaging and treatment on a novel 1.5 T MR-Linac radiotherapy hybrid device.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* existing indication for radiation therapy
* minimum age 18 years, no upper age limit
* capacity for consent
* Informed consent
Exclusion Criteria:
* contraindication for MRI (claustrophobia, metallic implants not applicable for MRI
* pregnancy
Contacts
No contact information available.